Dhampur Bio Organics Ltd has announced the complete resumption of manufacturing operations at its Unit Mansurpur facility, marking a significant operational milestone for the company. The announcement was made through a regulatory filing dated January 23, 2026, addressed to both BSE Limited and National Stock Exchange of India Ltd.

Operational Resumption Details

The company confirmed that complete normalcy in manufacturing operations at Unit Mansurpur has been resumed from January 23, 2026. This development follows earlier announcements made by the company on November 13, 2025, and November 14, 2025, regarding operational disruptions at the facility.

Safety and Insurance Coverage

The company emphasized important safety aspects of the incident that led to the operational disruption. Key safety and insurance details include:

• No loss of life or injuries were reported during the incident
• All assets are adequately covered under insurance
• Necessary coordination steps are being undertaken with the insurance company
• The company will keep exchanges informed as required under regulatory guidelines

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, indicating adherence to updated regulatory requirements for such disclosures.

Corporate Communication

The regulatory filing was signed by Ashu Rawat, Company Secretary & Compliance Officer, and was digitally authenticated on January 23, 2026. The communication was addressed to both major Indian stock exchanges where the company's shares are listed, ensuring comprehensive market disclosure of this operational development.

Dhampur Bio Organics Limited has released its investor presentation detailing Q3 FY26 financial performance and operational highlights. The leading cane processing company, with nine decades of experience, operates through three strategically located manufacturing facilities in Asmoli, Mansurpur, and Meerganj, focusing on value-added sugar manufacturing and bio-energy production.

Financial Performance Overview

The company's Q3 FY26 results demonstrate mixed performance across business segments. The sugar segment showed remarkable margin improvement despite revenue challenges, while other segments maintained relatively stable operations.

Sugar Segment Performance

The sugar segment delivered significant margin expansion during Q3 FY26:

Sugar production increased to 1,37,654 tons from 1,01,401 tons year-on-year, while average realisation improved to ₹41,316 per ton compared to ₹38,714 per ton in Q3 FY25. Sugar sales volume declined to 73,282 tons from 89,252 tons in the corresponding previous period.

Biofuels & Spirits Segment

The biofuels & spirits segment reported the following performance:

Ethanol production reached 14.45 million BL compared to 15.60 million BL in Q3 FY25, with average realisation at ₹61.99 per BL versus ₹64.02 per BL in the previous year.

Country Liquor Operations

The country liquor segment maintained steady performance with revenue of ₹28.94 crores and EBIT margin of 16.17%. Sales volume reached 11,47,686 cases with average realisation of ₹281.72 per case (net of excise duty).

Manufacturing Capacity and Infrastructure

Dhampur Bio Organics operates comprehensive manufacturing facilities with the following capacities:

The company also produces pharma grade sugar with 700 TPD capacity at the Asmoli plant, approved by Food Safety & Drug Administration authority, and operates domestic spirits production capacity of 8.0 million cases per year.

Nine-Month Performance Highlights

For the nine-month period FY26, the sugar segment achieved revenue of ₹1,319.74 crores with EBIT margin of 2.98%, while biofuels & spirits generated ₹306.22 crores revenue. The country liquor segment contributed ₹86.36 crores with EBIT margin of 15.88%.

Market Position and Strategy

The company continues positioning itself as a value-added sugar manufacturer and bio-energy company, with revenue contribution shifting towards non-sugar segments. The current revenue mix shows 82% from sugar and 18% from non-sugar segments, including biofuels & spirits and country liquor operations. Dhampur Bio Organics maintains its focus on enhancing production of niche, processed and value-added sugar products while moderating exposure to conventional sugar commodity price risks.